Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MHS Capital is an active venture capital firm based in San Francisco, California, founded in 2006. The firm invests primarily in early-stage companies across technology-driven sectors including software, consumer, e-commerce, mobile, education, and healthcare. It is not itself a biotech, pharma, or healthcare operating company; rather, it is a financial investor that has participated in healthcare and healthtech investments alongside broader technology investing. Publicly available profiles describe MHS Capital as a private venture investor with a long track record of seed and early-stage investing and multiple portfolio exits. For biotech analyst purposes, MHS Capital is best categorized as a generalist VC with some exposure to healthcare rather than a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MHS Capital.